- Home
- INZY vs PERF Comparison
INZY vs PERF Comparison
Compare INZY & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- PERF
- Stock Information
- Founded
- INZY 2015
- PERF 2015
- Country
- INZY United States
- PERF Taiwan
- Employees
- INZY N/A
- PERF N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- PERF Computer Software: Prepackaged Software
- Sector
- INZY Health Care
- PERF Technology
- Exchange
- INZY Nasdaq
- PERF Nasdaq
- Market Cap
- INZY 256.3M
- PERF 191.5M
- IPO Year
- INZY 2020
- PERF N/A
- Fundamental
- Price
- INZY N/A
- PERF $2.54
- Analyst Decision
- INZY Buy
- PERF Buy
- Analyst Count
- INZY 9
- PERF 1
- Target Price
- INZY $15.22
- PERF $5.00
- AVG Volume (30 Days)
- INZY 989.2K
- PERF 387.1K
- Earning Date
- INZY 08-05-2025
- PERF 07-23-2025
- Dividend Yield
- INZY N/A
- PERF N/A
- EPS Growth
- INZY N/A
- PERF 43.29
- EPS
- INZY N/A
- PERF 0.07
- Revenue
- INZY N/A
- PERF $61,927,000.00
- Revenue This Year
- INZY N/A
- PERF $15.86
- Revenue Next Year
- INZY N/A
- PERF $14.50
- P/E Ratio
- INZY N/A
- PERF $38.05
- Revenue Growth
- INZY N/A
- PERF 11.28
- 52 Week Low
- INZY $0.72
- PERF $1.51
- 52 Week High
- INZY $6.24
- PERF $3.44
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- PERF 79.45
- Support Level
- INZY $3.94
- PERF $2.15
- Resistance Level
- INZY $3.97
- PERF $2.32
- Average True Range (ATR)
- INZY 0.01
- PERF 0.16
- MACD
- INZY -0.08
- PERF 0.05
- Stochastic Oscillator
- INZY 100.00
- PERF 94.94
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.